Comparison of contrast media Dixopaque (Shahid Ghazi) and Visipaque

Phase 3

• Conditions: Patients candidated for coronary angiography by contrast media.; Ischemic Heart Diseases; 120-125

• Registration Number: IRCT201607254920N8
• Lead Sponsor: Shahid Ghazi Pharmaceutical Company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

patients aged between 45 to 65 years old; referred subjects for coronary angiography by contrast media; provided signed and dated informed consent subjects. Exclusion criteria: patients with contrast administration in the past 7 days; subjects have known contra-indication and allergy to contrast administration; renal insufficiency as defined by GFR < 50; lactation; pregnancy; bronchial asthma; clinical unstable condition (hemodynamic, respiratory, neurologic); emergency cases; hyperthyroidism; end-stage patients.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Image Quality. Timepoint: After coronary angiograghy. Method of measurement: Scoring by investigator from 1 to 10.

Secondary Outcome Measures

Name	Time	Method
Adverse events of contrast media. Timepoint: During injection and 24 after injection. Method of measurement: Interview, Physical exam, Lab test.;Renal toxicity. Timepoint: Before and 24 hours after injection. Method of measurement: Serum creatinine examination.